Our observations were in line with previous research that demonstrated the association of PTPN6 with poor prognosis in patients with bladder cancer and myelodysplastic syndromes [11] and its potential role as a tumor suppressor in esophagus cancer [18]. This evidence concerns the gene PTPN6 and urinary bladder cancer.